XML 19 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Marketable Securities
At December 31, 2019 and 2018, the fair value of marketable securities are as follows:
 
December 31,
 
2019
 
2018
 
(In thousands)
Available-for-sale marketable debt securities
$
19,993

 
$
123,246

Marketable equity security

 
419

     Total marketable securities
$
19,993

 
$
123,665


Schedule of Current Available-for-sale Marketable Securities
At December 31, 2018, current available-for-sale marketable debt securities are as follows:
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
(In thousands)
Treasury discount notes
$
112,291

 
$
3

 
$
(3
)
 
$
112,291

Commercial paper
10,955

 

 

 
10,955

Total available-for-sale marketable debt securities
$
123,246

 
$
3

 
$
(3
)
 
$
123,246


At December 31, 2019, current available-for-sale marketable debt securities are as follows:
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
(In thousands)
Commercial paper
$
19,993

 
$

 
$

 
$
19,993

Total available-for-sale marketable debt securities
$
19,993

 
$

 
$

 
$
19,993


Schedule of Proceeds from Maturities and Sales of Current Available-for-sale Marketable Securities
The following table presents the proceeds from maturities of available-for-sale marketable debt securities:
 
December 31,
 
2019
 
2018
 
2017
 
(In thousands)
Proceeds from maturities of available-for-sale marketable debt securities
$
163,500

 
$
333,600

 
$
114,350


Schedule of Long-term Investments
Long-term investments consist of:
 
December 31,
 
2019
 
2018
 
(In thousands)
Equity securities without readily determinable fair values
$
353,052

 
$
235,055

Total long-term investments
$
353,052

 
$
235,055


Schedule of Realized and Unrealized Gains (Losses) on Investments
 
Years Ended December 31,
 
2019
 
2018
 
(In thousands)
Upward adjustments (gross unrealized gains)
$
19,698

 
$
128,986

Downward adjustments including impairments (gross unrealized losses)
(5,193
)
 
(4,931
)
Total
$
14,505

 
$
124,055

The cumulative upward and downward adjustments (including impairments) to the carrying value of equity securities without readily determinable fair values held at December 31, 2019 were $19.9 million and $7.0 million, respectively.
Realized and unrealized gains and losses for the Company's marketable equity security and investments without readily determinable fair values for the years ended December 31, 2019 and 2018 are as follows:
 
Years Ended December 31,
 
2019
 
2018
 
(In thousands)
Realized gains, net, for equity securities sold
$
23,076

 
$
27,874

Unrealized gains, net, on equity securities held
14,505

 
124,170

Total gains recognized, net, in other income (expense), net
$
37,581

 
$
152,044


Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
The following tables present the Company's financial instruments that are measured at fair value on a recurring basis:
 
December 31, 2019
 
Quoted Market
Prices in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Fair Value
Measurements
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
2,164,576

 
$

 
$

 
$
2,164,576

Treasury discount notes

 
199,896

 

 
199,896

Time deposits

 
128,075

 

 
128,075

Commercial paper

 
29,960

 

 
29,960

Marketable securities:
 
 
 
 
 
 
 
Commercial paper

 
19,993

 

 
19,993

Other non-current assets:


 
 
 
 
 
 
Warrant

 

 
8,495

 
8,495

Total
$
2,164,576

 
$
377,924

 
$
8,495

 
$
2,550,995

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Contingent consideration arrangements
$

 
$

 
$
(6,918
)
 
$
(6,918
)
 
December 31, 2018
 
Quoted Market
Prices in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Fair Value
Measurements
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
880,815

 
$

 
$

 
$
880,815

Treasury discount notes

 
561,733

 

 
561,733

Commercial paper

 
162,417

 

 
162,417

Time deposits

 
90,036

 

 
90,036

Marketable securities:
 

 
 

 
 

 
 
Treasury discount notes

 
112,291

 

 
112,291

  Commercial paper

 
10,955

 

 
10,955

Marketable equity security
419

 

 

 
419

Total
$
881,234

 
$
937,432

 
$

 
$
1,818,666

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Contingent consideration arrangements
$

 
$

 
$
(28,631
)
 
$
(28,631
)

Schedule of Unobservable Inputs in Fair Value Measurement
The following table presents the changes in the Company's financial instruments that are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
 
Years Ended December 31,
 
2019
 
2018
 
Warrant
 
Contingent
Consideration
Arrangements
 
Contingent
Consideration
Arrangements
 
(In thousands)
Balance at January 1
$

 
$
(28,631
)
 
$
(2,647
)
Fair value at date of acquisition
17,618

 

 
(25,521
)
Total net (losses) gains:
 
 
 
 
 
Included in earnings:
 
 
 
 
 
Fair value adjustments
(9,123
)
 
19,739

 
(1,456
)
Included in other comprehensive (loss) income

 
(14
)
 
45

Settlements

 
1,988

 
948

Balance at December 31
$
8,495

 
$
(6,918
)
 
$
(28,631
)

Schedule of Carrying Value and the Fair Value of Financial Instruments Measured at Fair Value Only for Disclosure Purposes
The following table presents the carrying value and the fair value of financial instruments measured at fair value only for disclosure purposes:
 
December 31, 2019
 
December 31, 2018
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
 
Fair
Value
 
(In thousands)
Current portion of long-term debt
$
(13,750
)
 
$
(13,681
)
 
$
(13,750
)
 
$
(12,753
)
Long-term debt, net(a)
(3,121,572
)
 
(4,136,988
)
 
(2,245,548
)
 
(2,460,204
)
_________________
(a) 
At December 31, 2019 and 2018, the carrying value of long-term debt, net includes unamortized original issue discount and debt issuance costs of $404.7 million and $88.9 million, respectively.